Hepatorenal Syndrome Drug Hopes Third Time’s a Charm With FDA

(MedPage Today) — Respiratory failure risk loomed large in an FDA staff review of data supporting terlipressin for an indication in the more severe type 1 phenotype of hepatorenal syndrome (HRS-1).
In documents released ahead of Wednesday’s meeting…
Read More

Leave a Reply

%d bloggers like this: